HT VET Brings VISTA iQ's 40-Second Cancer Screening to London Vet Show 2026
)
"Wait and see" has been the default response to a new lump for too long, and too many pets go home with uncertainty instead of a plan. VISTA iQ was built to change that: a nurse or technician can scan a mass in under a minute, before the vet even enters the room, using Heat Diffusion Imaging (HDI) to compare how a mass responds to controlled, gentle heat against the surrounding healthy tissue. The result is a Cancer Risk Value, validated to 90% sensitivity and 98% negative predictive value, that helps the clinical team decide whether to monitor, investigate further, or act now, all without an invasive sample.
VISTA iQ is a screening tool, not a diagnosis: it supports, rather than replaces, clinical judgement, and every result is interpreted by the vet before any decision is made. It has now been used in more than 40,000 scans across clinics already using the device, and this year's London Vet Show will be the first opportunity for many delegates to see a live scan in person.
At Stand Y63, London Vet Show 2026 delegates can:
– See VISTA iQ scan a mass live, start to finish, in under a minute
– Speak to the HT VET team about how VISTA iQ fits into a nurse-led triage workflow
– Take home a free set of Calipers, no registration required, simply for visiting the stand
"London Vet Show is one of the best opportunities each year to put VISTA iQ directly in front of the people making the call on a new lump," said Dr Liron Levy-Hirsch, Managing Director, HT VET. VISTA iQ is available now to UK veterinary practices. Practices interested in a demonstration ahead of or after the show can book directly at ht-vet.com.
About HT VET
HT VET is the company behind VISTA iQ, a non-invasive, AI-powered first-step cancer screening device for canine cutaneous and subcutaneous masses. Using Heat Diffusion Imaging (HDI), VISTA iQ delivers an in-clinic result in around 40 seconds, giving veterinary teams a fast, evidence-based starting point for deciding next steps on lumps and bumps, without the wait or invasiveness of cytology or biopsy. VISTA iQ is designed to be led by nurses, with results interpreted by the vet, making early screening accessible to every clinic, not just specialists.
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
